In children with developmental and epileptic encephalopathies, use of topical cannabidiol gel along with antiseizure therapy can improve quality of life. The safety and tolerability of cannabidiol gel was studied on 48 children, aged 3 to 13 years, in an open-label, non-randomized controlled trial. After the initial month of baseline and titration period, patients were […]
Maximize the informational quality of your email inbox by selectively subscribing to evidence-based health and wellness resources that are informed by rigorous scientific research and medical expertise.
Your privacy is important to us
© 2020-2022 HealthSciaxis a Sciaxis Company. All rights reserved. Our website services, content, and products are for informational purposes only. HealthSciaxis does not provide medical advice, diagnosis, or treatment. See additional information.
